← Back to headlines
Biotech Stock Surges Over 1,000% Since July, Jefferies Predicts Further Gains
A clinical-stage biotechnology stock has seen a dramatic increase of over 1,000% since late July, with Jefferies initiating coverage at a buy rating and anticipating additional gains.
16 Mar, 11:02 — 16 Mar, 11:02
Sources
Showing 1 of 1 sources
